SKU(재고 관리 코드):E-AB-F1137C-20Tests
FITC Anti-Human CD45 Antibody[HI30]
FITC Anti-Human CD45 Antibody[HI30]
The FITC Anti-Human CD45 Antibody [HI30] is a highly specialized and meticulously crafted product designed to facilitate accurate and efficient identification and analysis of human CD45 antigen expression. This antibody, conjugated with Fluorescein Isothiocyanate (FITC), offers exceptional sensitivity and specificity, making it an invaluable tool for researchers and clinicians alike.
The CD45 antigen, also known as leukocyte common antigen (LCA), is a transmembrane protein expressed on all nucleated cells of hematopoietic origin. It plays a crucial role in the regulation of immune responses and cell signaling. The FITC Anti-Human CD45 Antibody [HI30] specifically targets the CD45 antigen, enabling the discrimination of leukocytes from non-leukocytes in various biological samples.
This antibody has been meticulously developed using advanced techniques and stringent quality control measures to ensure optimal performance and reliability. It exhibits exceptional binding affinity and minimal non-specific binding, resulting in highly accurate and reproducible results. The FITC conjugation further enhances its utility by enabling direct visualization of CD45 expression through fluorescence microscopy or flow cytometry.
The FITC Anti-Human CD45 Antibody [HI30] is supplied in a convenient and user-friendly format, allowing for easy integration into existing laboratory protocols. It is provided as a liquid formulation, eliminating the need for time-consuming reconstitution steps. The antibody is also available in various sizes to accommodate different experimental requirements.
This product has been extensively validated and is suitable for a wide range of applications, including immunohistochemistry, immunocytochemistry, and flow cytometry. It is compatible with multiple sample types, including peripheral blood, bone marrow, and lymphoid tissues.
In summary, the FITC Anti-Human CD45 Antibody [HI30] is a meticulously developed and highly reliable tool for the accurate identification and analysis of human CD45 antigen expression. Its exceptional sensitivity, specificity, and user-friendly format make it an indispensable asset for researchers and clinicians in the field of immunology and hematology.
The CD45 antigen, also known as leukocyte common antigen (LCA), is a transmembrane protein expressed on all nucleated cells of hematopoietic origin. It plays a crucial role in the regulation of immune responses and cell signaling. The FITC Anti-Human CD45 Antibody [HI30] specifically targets the CD45 antigen, enabling the discrimination of leukocytes from non-leukocytes in various biological samples.
This antibody has been meticulously developed using advanced techniques and stringent quality control measures to ensure optimal performance and reliability. It exhibits exceptional binding affinity and minimal non-specific binding, resulting in highly accurate and reproducible results. The FITC conjugation further enhances its utility by enabling direct visualization of CD45 expression through fluorescence microscopy or flow cytometry.
The FITC Anti-Human CD45 Antibody [HI30] is supplied in a convenient and user-friendly format, allowing for easy integration into existing laboratory protocols. It is provided as a liquid formulation, eliminating the need for time-consuming reconstitution steps. The antibody is also available in various sizes to accommodate different experimental requirements.
This product has been extensively validated and is suitable for a wide range of applications, including immunohistochemistry, immunocytochemistry, and flow cytometry. It is compatible with multiple sample types, including peripheral blood, bone marrow, and lymphoid tissues.
In summary, the FITC Anti-Human CD45 Antibody [HI30] is a meticulously developed and highly reliable tool for the accurate identification and analysis of human CD45 antigen expression. Its exceptional sensitivity, specificity, and user-friendly format make it an indispensable asset for researchers and clinicians in the field of immunology and hematology.